177 related articles for article (PubMed ID: 22726391)
21. Prevalence of herpes simplex types 1 and 2, varicella zoster virus, cytomegalovirus, immunoglobulin G antibodies among female university students in Syria.
Barah F
Saudi Med J; 2012 Sep; 33(9):990-4. PubMed ID: 22964811
[TBL] [Abstract][Full Text] [Related]
22. Is there a change in cytomegalovirus seroepidemiology in Spain?
de Ory F; Ramírez R; García Comas L; León P; Sagües MJ; Sanz JC
Eur J Epidemiol; 2004; 19(1):85-9. PubMed ID: 15012028
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of parvovirus B19 antibodies in pregnant women in northern Benin.
De Paschale M; Ceriani C; Cerulli T; Cagnin D; Cavallari S; Zaongo D; Diombo K; Priuli G; Viganò P; Finazzi S; Clerici P
Trop Med Int Health; 2023 Mar; 28(3):226-231. PubMed ID: 36647788
[TBL] [Abstract][Full Text] [Related]
24. The lack of routine surveillance of Parvovirus B19 infection in pregnancy prevents an accurate understanding of this regular cause of fetal loss and the risks posed by occupational exposure.
Watt AP; Brown M; Pathiraja M; Anbazhagan A; Coyle PV
J Med Microbiol; 2013 Jan; 62(Pt 1):86-92. PubMed ID: 22977072
[TBL] [Abstract][Full Text] [Related]
25. Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the first eight years of life: a prospective study.
Aarnisalo J; Ilonen J; Vainionpää R; Volanen I; Kaitosaari T; Simell O
Scand J Infect Dis; 2003; 35(10):750-3. PubMed ID: 14606615
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
[TBL] [Abstract][Full Text] [Related]
27. Human parvovirus B19 and low hemoglobin levels in pregnant Sudanese women.
Gasim GI; Eltayeb R; Elhassan EM; Haggaz AD; Rayis DA; Adam I
Int J Gynaecol Obstet; 2016 Mar; 132(3):318-20. PubMed ID: 26674318
[TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus seropositivity is associated with herpes zoster.
Ogunjimi B; Hens N; Pebody R; Jansens H; Seale H; Quinlivan M; Theeten H; Goossens H; Breuer J; Beutels P
Hum Vaccin Immunother; 2015; 11(6):1394-9. PubMed ID: 25905443
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa.
Compston LI; Li C; Sarkodie F; Owusu-Ofori S; Opare-Sem O; Allain JP
J Med Virol; 2009 Nov; 81(11):1860-8. PubMed ID: 19774687
[TBL] [Abstract][Full Text] [Related]
30. Immunity to varicella zoster virus among pregnant women in the Norwegian Mother and Child Cohort Study.
Mirinaviciute G; Barlinn R; Gjeruldsen Dudman S; Flem E
PLoS One; 2019; 14(8):e0221084. PubMed ID: 31408478
[TBL] [Abstract][Full Text] [Related]
31. Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil.
Slavov SN; Rodrigues ES; Sauvage V; Caro V; Diefenbach CF; Zimmermann AM; Covas DT; Laperche S; Kashima S
J Med Virol; 2019 Jul; 91(7):1224-1231. PubMed ID: 30851123
[TBL] [Abstract][Full Text] [Related]
32. High incidence of maternal parvovirus B19 infection in a large unselected population-based pregnancy cohort in Norway.
Barlinn R; Rollag H; Trogstad L; Vainio K; Basset C; Magnus P; Dudman SG
J Clin Virol; 2017 Sep; 94():57-62. PubMed ID: 28759773
[TBL] [Abstract][Full Text] [Related]
33. Seroprevalence of parvovirus B19 antibodies among young pregnant women or planning pregnancy, tested for toxoplasmosis.
Zajkowska A; Garkowski A; Czupryna P; Moniuszko A; Król ME; Szamatowicz J; Pancewicz S
Przegl Epidemiol; 2015; 69(3):479-82, 597-600. PubMed ID: 26519843
[TBL] [Abstract][Full Text] [Related]
34. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study.
van Gessel PH; Gaytant MA; Vossen AC; Galama JM; Ursem NT; Steegers EA; Wildschut HI
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):46-9. PubMed ID: 16406220
[TBL] [Abstract][Full Text] [Related]
35. Microsphere-Based IgM and IgG Avidity Assays for Human Parvovirus B19, Human Cytomegalovirus, and Toxoplasma gondii.
Wang Y; Hedman L; Nurmi V; Ziemele I; Perdomo MF; Söderlund-Venermo M; Hedman K
mSphere; 2020 Mar; 5(2):. PubMed ID: 32188754
[TBL] [Abstract][Full Text] [Related]
36. Changes in cytomegalovirus seroprevalence in pregnant Japanese women-a 10-year single center study.
Taniguchi K; Watanabe N; Sato A; Jwa SC; Suzuki T; Yamanobe Y; Sago H; Kozuka K
J Clin Virol; 2014 Mar; 59(3):192-4. PubMed ID: 24468011
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of pregnancy-relevant infections in a rural setting of Ghana.
Völker F; Cooper P; Bader O; Uy A; Zimmermann O; Lugert R; Groß U
BMC Pregnancy Childbirth; 2017 Jun; 17(1):172. PubMed ID: 28583150
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
39. Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.
Juhl D; Görg S; Hennig H
Vox Sang; 2014 Oct; 107(3):226-32. PubMed ID: 24916600
[TBL] [Abstract][Full Text] [Related]
40. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications.
Korndewal MJ; Mollema L; Tcherniaeva I; van der Klis F; Kroes AC; Oudesluys-Murphy AM; Vossen AC; de Melker HE
J Clin Virol; 2015 Feb; 63():53-8. PubMed ID: 25600606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
